Evidence map›Paper›PMID 35846213›Full record

ArticleEJHaem2022

Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia.

Philip Crispin, Sarah Hicks, Lucy A Coupland, Sidra Ali, Elizabeth E Gardiner

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Philip CrispinACRF Department of Cancer Biology and Therapeutics The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.ORCID https://orcid.org/0000-0002-4124-4971
Sarah HicksACRF Department of Cancer Biology and Therapeutics The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.
Lucy A CouplandACRF Department of Cancer Biology and Therapeutics The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.
Sidra AliACRF Department of Cancer Biology and Therapeutics The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.
Elizabeth E GardinerACRF Department of Cancer Biology and Therapeutics The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.
Australian National University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelet transfusions are not always available for bleeding in severe thrombocytopenia, as storage outside of major centers is limited by their short shelf-life. Data are lacking to support alternative available blood products; however, additional fibrinogen has been shown to enhance clot formation in vitro. To test the hypothesis that cryoprecipitate supplementation could improve clot formation in severe thrombocytopenia, eight hematological malignancy patients with platelet counts under 10 × 10

Indexed as

cryoprecipitatecryopreserved plateletsthrombocytopeniathromboelastometrytransfusion

Identifiers

PMID35846213
PMCPMC9175722
OpenAlexW4200112028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.